US Patent 11377467 Crystalline form of gemcitabine
Patent 11377467 was granted and assigned to NuCana on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Hugh Griffith0
Edits on 21 Mar, 2023
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113774670
Date of Patent
July 5, 2022
0Patent Application Number
160653690
Date Filed
December 21, 2016
0Patent Citations
Patent Primary Examiner
Edits on 6 Jul, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+104 characters)
US Patent 11377467 Crystalline form of gemcitabine
Article
This invention relates to a crystalline form of gemcitabine-[phenyl-(benzoxy-L-alaninyl)]-(S)-phosphate.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11377467
Date of patent
July 5, 2022
Patent application number
16065369
Date Filed
December 21, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 11377467 Crystalline form of gemcitabine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
